ELE Biotech has developed ELEarly Dementia, a biotechnology platform for the early detection of the risk of neurodegenerative diseases. It combines a qPCR-based blood test kit with clinical interpretation software, enabling accessible, scalable screening that can be integrated into hospitals and laboratories. Its mission is to make early diagnosis more widely available and to help healthcare systems stay one step ahead of dementia.
José Bayón, dir. public affairs GDELS
Gonzalo León, executive committee Innovative Companies Forum
Micaela Martelli, Director of Sectorial Solutions Telefónica
Blanca Caballero, CEO Nanological
Carolina Gago, COO IOT Lenses
Amalio Garrido, CEO Drage&Mate
Mª Jesús Romero, dir. of economy and industry, Madrid City Council
Marina Villegas, General Director of Research and Technological Innovation Community of Madrid
Mª Inmaculada López, Director Compluemprende
Eduardo Díaz, Director of EBT Office Fund. Madri+d
Luis Baratas, head of entrepreneurship sector, ICEX